SEARCH

SEARCH BY CITATION

References

  • 1
    Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996; 16: 12505.
  • 2
    Doll R, Hill AB. Mortality of British doctors in relation to smoking; observation on coronary thrombosis. In: HaenzelW, ed. Epedemiological Approaches to the Study of Cancer and Other Chronic Disease. National Cancer Institute Monograph No. 19, Bethesda, MD, USA: US Department of Health, Education and Welfare, 1966; 99: 20568.
  • 3
    Boer JM, Fesken EJ, Verschuren WM, Seidell JC, Kromhout D. The joint impact of family history of myocardial infarction and other risk factors on 12-year coronary heart disease mortality. Epidemiology 1999; 10: 76770.
  • 4
    Hawe E, Talmud PJ, Miller GJ, Humphries SE. Family history is a coronary heart disease risk factor in the second Northwick Park Heart Study. Ann Hum Genet, in press.
  • 5
    Marenberg ME, Risch N, Berkman LF, Floderus B, De Flaire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 10416.
  • 6
    Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kaousdian S, Kannell WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986; 256: 28358.
  • 7
    Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 2139.
  • 8
    Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 5337.
  • 9
    Ross R. Atherosclerosis – an inflammatory disease. New Engl J Med 1999; 340: 11526.
  • 10
    Heath KE, Humphries SE, Middleton-Price H, Boxer M. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom. Eur J Hum Genet 2001; 9: 24452.
  • 11
    Talmud PJ, Humphries SE. Gene:environment interaction in lipid metabolism and effect on coronary heart disease. Curr Opin Lipid 2002; 13: 14954.
  • 12
    Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988; 8: 121.
  • 13
    Humphries SE, Talmud PJ, Hawe E, Bolla M, Day INM, Miller GJ. ApoE4 increases the risk of coronary heart disease in middle-aged men who smoke: Second Northwick Park Heart Study. Lancet 2001; 358: 1159.
  • 14
    Kessler C, Spitzer C, Stauske D et al. The apolipoprotein E and the beta-fibrinogen G/A-455 gene polymorphisms are associated with ischaemic stroke and latge-vessel disease. Arterioscler Thromb Vasc Biol 1997; 17: 28804.
  • 15
    Gerdes LU, Gerdes C, Kervinen K et al. The apolipoprotein epsilon allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocsrdial infarction: a substudy of the Scandinavian Simvastatin Survival Study. Circulation 2000; 101: 136671.
  • 16
    Smith JD, Miyata M, Poulin SE, Neveux LM, Craig WY. The relationship between apoliporotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent. Int J Clin Lab Res 1998; 28: 11621.
  • 17
    Cullen P, Cingarella A, Brennhausen B, Mohr S, Assmann G, Von Eckardstein A. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human derived monocyte-derived macrophages. J Clin Invest 2000; 101: 160777.
  • 18
    Talmud PJ, Hawe E, Miller GJ. Analysis of gene–enviroment interaction in coronary disease: lipoprotein lipase and smoking as examples. Ital Heart J 2002; 3: 69.
  • 19
    Olivecrona G, Olivecrona T. Triglyceride lipase and atherosclerosis. Curr Opin Lipidol 1995; 6: 291305.
  • 20
    Beisiegel U, Weber W, Bengtsson-Oliveecrono G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 1991; 88: 83426.
  • 21
    Fisher RM, Humphries SE, Talmud PJ. Common variation in the lipoprotein lipase gene: effects of plasma lipids and atherosclerosis. Atherosclerosis 1997; 13: 14559.
  • 22
    Talmud PJ, Bujac SR, Hall S, Miller GJ, Humphries SE. Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers. Atherosclerosis 2000; 149: 7581.
  • 23
    Keller ET, Wanagat J, Ershler WM. Molecular and cellular biology of interleukin-6 and its receptor. Frontiers in Bioscience 1996; 1: 34057.
  • 24
    Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 62136.
  • 25
    Mohamed-Ali V, Goodrick S, Rawesh A et al. Human subcutaneous adipose tissue releases il-6 but not TNF-a in vivo. J Clin Endo Metab 1997; 82: 4196200.
  • 26
    Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. NEJM 2000; 342: 83643.
  • 27
    Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 176772.
  • 28
    Gabriel AS, Ahnve S, Wretlind B, Martinson A. IL-6 and IL-1 receptor antagonists in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction. JIM 2000; 248: 616.
  • 29
    Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 136976.
  • 30
    UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasound surveillance for small abdominal aortic aneurysms. Lancet 1998; 352: 164955.
  • 31
    Jones KG, Brull DJ, Brown LC et al. Interleukin-6, (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001; 103: 22605.
  • 32
    Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6 – 174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 224352.
  • 33
    Georges JL, Loukaci V, Poirer O et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. J Mol Med 2001; 79: 3005.
  • 34
    Humphries SE, Donati MB. Analysis of gene–enviroment interaction in coronary artery disease. Ital Heart J 2002; 3: 35.
  • 35
    Allen DR, Browse NL, Rutt DL, Butler L, Fletcher C. The effect of cigarette smoke, nicotine and carbon monoxide on the permeability of the arterial wall. J Vasc Surg 1998; 7: 13952.
  • 36
    Blann AD. The acute influence of smoking on the endothelium. Atherosclerosis 1992; 96: 24950.
  • 37
    Loew GD. Blood viscosity and cardiovascular risk. Curr Opin Lipidol 1993; 4: 2837.
  • 38
    Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Astherosclerosis 1997; 129: 7988.
  • 39
    Lowe GDO, Rumley A. Coagulation, fibrinolysis and cardiovascular disease. Fibrinolysis & Proteolysis 1999; 13: 918.
  • 40
    Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GDO. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevelent cardiovascular disease. B J Haem 1999; 104: 24657.
  • 41
    Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titres of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994; 14: 60516.
  • 42
    Saxena U, Goldberg IJ. Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interaction and monocyte recruitement. Curr Opin Lipidol 1994; 5: 31622.
  • 43
    Hedriks WL, Van Der Boom H, Van Vark LC, Havekes LM. Lipoprotein lipase stimulates the binding and uptake of moderately oxidizable low-density lipoprotein by J774 macrophages. Biochem J 1996; 314: 5638.